| Irene Shin, | |
|
21515 Hawthorne Blvd Ste G100, Torrance, CA 90503-6501 | |
| (424) 571-2618 | |
| (424) 571-2339 |
| Full Name | Irene Shin |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 21515 Hawthorne Blvd Ste G100, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013477223 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 24407 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Irene Shin, 6160 Cornerstone Ct E Ste 100, San Diego, CA 92121-3724 Ph: (858) 216-8837 | Irene Shin, 21515 Hawthorne Blvd Ste G100, Torrance, CA 90503-6501 Ph: (424) 571-2618 |
News Archive
Republicans' proposed foreign aid cuts could damage food security programs in the developing world and create social instability requiring U.S. military intervention, advocates and government officials said on Thursday at a Capitol Hill event addressing hunger and rising food prices, Agence France-Presse reports (Zeitvogel, 3/3).
Clopidogrel (Plavix) is used worldwide in millions of patients after placement of coronary artery stents. Sales of the drug exceed 5 billion US dollars.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
› Verified 9 days ago
Stephanie Hoffman, MA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19401 S Vermont Ave, Suite A-200, Torrance, CA 90502 Phone: 310-323-6887 | |
Valerie Rougeau, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1815 W. 213th Street, Suite 100, Torrance, CA 90501 Phone: 310-328-0693 Fax: 310-328-7058 | |
Mrs. Amanda Michelle Littlejohn, MS OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 310, Torrance, CA 90505 Phone: 310-370-1200 | |
Dana Granado, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19401 S Vermont Ave, Suite A-200, Torrance, CA 90502 Phone: 310-323-6887 | |
Ms. Kimberly Marie Ford, MA, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3475 Torrance Blvd, Suite B-2, Torrance, CA 90503 Phone: 310-316-7748 | |
Heather Hudgins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18512 Hawthorne Blvd, Torrance, CA 90504 Phone: 310-371-8555 Fax: 310-371-4488 |